Literature DB >> 9704590

Hypoosmolarity induces an increase of extracellular N-acetylaspartate concentration in the rat striatum.

S E Davies1, M Gotoh, D A Richards, T P Obrenovitch.   

Abstract

We previously showed that extracellular levels of N-acetylaspartate (NAA) increase when a medium with reduced NaCl concentration is perfused through a microdialysis probe, and proposed that NAA may be released during hypoosmotic swelling. Here, we demonstrate that this effect is due to hypoosmolarity of the perfusion medium, and not to low NaCl. NAA changes in the dialysate were compared with those of taurine as the osmoregulatory role of this amino acid is established. Reduction of the NaCl concentration in the perfusion medium increased the dialysate levels of NAA and taurine, but this effect was abolished when NaCl was replaced by sucrose to maintain isosmolarity. The NAA response to hypoosmolarity was smaller than that of taurine, but it may still be important to neurons as NAA is predominantly neuronal in the mammalian CNS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704590     DOI: 10.1023/a:1020778832745

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Relation between release of taurine and phosphoethanolamine and osmoregulation in experimental epilepsy.

Authors:  A Lehmann
Journal:  Epilepsy Res Suppl       Date:  1992

2.  Quantitative analysis of rat synaptosomes and cerebrum using high-resolution 1H magnetic resonance spectroscopy.

Authors:  O A Petroff; A P Burlina; J Black; J W Prichard
Journal:  Clin Chim Acta       Date:  1992-03-13       Impact factor: 3.786

3.  Changes in extracellular acid-base homeostasis in cerebral ischemia.

Authors:  D L Taylor; T P Obrenovitch; L Symon
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

4.  Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.

Authors:  R Matalon; K Michals; D Sebesta; M Deanching; P Gashkoff; J Casanova
Journal:  Am J Med Genet       Date:  1988-02

5.  Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia.

Authors:  T N Sager; A Fink-Jensen; A J Hansen
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

Review 6.  A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system.

Authors:  M H Baslow
Journal:  J Neurochem       Date:  1997-04       Impact factor: 5.372

7.  Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model.

Authors:  L H Monsein; V P Mathews; P B Barker; C A Pardo; S J Blackband; W D Whitlow; D F Wong; R N Bryan
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jul-Aug       Impact factor: 3.825

8.  Reversible decreases in N-acetylaspartate after acute brain injury.

Authors:  N De Stefano; P M Matthews; D L Arnold
Journal:  Magn Reson Med       Date:  1995-11       Impact factor: 4.668

Review 9.  N-acetylaspartate in neuropsychiatric disorders.

Authors:  G Tsai; J T Coyle
Journal:  Prog Neurobiol       Date:  1995-08       Impact factor: 11.685

10.  Investigation into the role of N-acetylaspartate in cerebral osmoregulation.

Authors:  D L Taylor; S E Davies; T P Obrenovitch; M H Doheny; P N Patsalos; J B Clark; L Symon
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

View more
  9 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine.

Authors:  Su Xu; Jaylyn Waddell; Wenjun Zhu; Da Shi; Andrew D Marshall; Mary C McKenna; Rao P Gullapalli
Journal:  Magn Reson Med       Date:  2014-12-02       Impact factor: 4.668

Review 3.  N-acetylaspartate in the vertebrate brain: metabolism and function.

Authors:  Morris H Baslow
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

Review 4.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

5.  NMR-Based Metabolomics Reveal a Recovery from Metabolic Changes in the Striatum of 6-OHDA-Induced Rats Treated with Basic Fibroblast Growth Factor.

Authors:  Hong Zheng; Liangcai Zhao; Huanhuan Xia; Cuicui Xu; Dan Wang; Kun Liu; Li Lin; Xiaokun Li; Zhihan Yan; Hongchang Gao
Journal:  Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.590

6.  Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.

Authors:  Da Shi; Su Xu; Jaylyn Waddell; Susanna Scafidi; Steven Roys; Rao P Gullapalli; Mary C McKenna
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

7.  In vitro studies on the putative function of N-acetylaspartate as an osmoregulator.

Authors:  Mattias Tranberg; Abdul-Karim Abbas; Mats Sandberg
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

8.  Extracellular N-Acetylaspartate in Human Traumatic Brain Injury.

Authors:  Richard J Shannon; Susan van der Heide; Eleanor L Carter; Ibrahim Jalloh; David K Menon; Peter J Hutchinson; Keri L H Carpenter
Journal:  J Neurotrauma       Date:  2015-08-14       Impact factor: 5.269

9.  Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.

Authors:  Georg von Jonquieres; Ziggy H T Spencer; Benjamin D Rowlands; Claudia B Klugmann; Andre Bongers; Anne E Harasta; Kristina E Parley; Jennie Cederholm; Orla Teahan; Russell Pickford; Fabien Delerue; Lars M Ittner; Dominik Fröhlich; Catriona A McLean; Anthony S Don; Miriam Schneider; Gary D Housley; Caroline D Rae; Matthias Klugmann
Journal:  Acta Neuropathol       Date:  2017-11-07       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.